Analysts: WellPoint Inc (WLP.N)
WLP.N on New York Stock Exchange
76.98USD
24 May 2013
76.98USD
24 May 2013
Price Change (% chg)
$-1.00 (-1.28%)
$-1.00 (-1.28%)
Prev Close
$77.98
$77.98
Open
$77.20
$77.20
Day's High
$77.52
$77.52
Day's Low
$76.18
$76.18
Volume
484,236
484,236
Avg. Vol
475,316
475,316
52-wk High
$79.58
$79.58
52-wk Low
$52.52
$52.52
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 2.09 | December | 25 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 7 | 5 | 5 | 5 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 12 | 14 | 14 | 14 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.33 | 2.52 | 2.52 | 2.52 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 11 | 17,897.80 | 18,350.00 | 17,689.60 | 16,082.50 |
| Quarter Ending Sep-13 | 11 | 17,897.00 | 18,174.00 | 17,665.00 | 16,325.00 |
| Year Ending Dec-13 | 12 | 71,807.30 | 76,895.00 | 70,944.00 | 64,319.30 |
| Year Ending Dec-14 | 11 | 76,502.90 | 80,602.00 | 73,956.90 | 70,280.10 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 19 | 2.09 | 2.66 | 1.82 | 2.27 |
| Quarter Ending Sep-13 | 19 | 1.98 | 2.15 | 1.85 | 2.22 |
| Year Ending Dec-13 | 20 | 8.02 | 8.34 | 7.87 | 8.57 |
| Year Ending Dec-14 | 20 | 8.27 | 9.05 | 7.49 | 8.99 |
| LT Growth Rate (%) | 2 | 11.50 | 12.00 | 11.00 | 9.81 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 18,026.60 | 17,546.30 | 480.29 | 2.66 |
| Quarter Ending Dec-12 | 15,280.80 | 15,271.30 | 9.55 | 0.06 |
| Quarter Ending Sep-12 | 15,306.20 | 15,133.70 | 172.53 | 1.13 |
| Quarter Ending Jun-12 | 15,273.50 | 15,173.30 | 100.20 | 0.66 |
| Quarter Ending Mar-12 | 15,272.60 | 15,150.20 | 122.43 | 0.80 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 2.38 | 2.94 | 0.56 | 23.27 |
| Quarter Ending Dec-12 | 0.95 | 1.03 | 0.08 | 8.58 |
| Quarter Ending Sep-12 | 1.84 | 2.09 | 0.25 | 13.79 |
| Quarter Ending Jun-12 | 2.07 | 2.04 | 0.03 | 1.66 |
| Quarter Ending Mar-12 | 2.27 | 2.34 | 0.07 | 2.97 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 17,897.80 | 17,913.20 | 18,065.30 | 18,091.20 | 16,082.50 |
| Quarter Ending Sep-13 | 17,897.00 | 17,889.90 | 17,926.40 | 17,925.90 | 16,325.00 |
| Year Ending Dec-13 | 71,807.30 | 71,382.00 | 71,903.60 | 71,890.70 | 64,319.30 |
| Year Ending Dec-14 | 76,502.90 | 76,428.90 | 77,541.90 | 77,754.20 | 70,280.10 |
| Earnings (per share) | |||||
| Quarter Ending Jun-13 | 2.09 | 2.09 | 2.11 | 2.12 | 2.27 |
| Quarter Ending Sep-13 | 1.98 | 1.99 | 2.08 | 2.08 | 2.22 |
| Quarter Ending Dec-13 | 8.02 | 7.99 | 7.78 | 7.82 | 8.57 |
| Quarter Ending Dec-14 | 8.27 | 8.27 | 8.17 | 8.15 | 8.99 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 1 | 1 | 9 |
| Quarter Ending Sep-13 | 1 | 0 | 3 | 7 |
| Year Ending Dec-13 | 0 | 1 | 1 | 9 |
| Year Ending Dec-14 | 1 | 0 | 3 | 7 |
| Earnings | ||||
| Quarter Ending Jun-13 | 0 | 1 | 3 | 15 |
| Quarter Ending Sep-13 | 0 | 1 | 0 | 15 |
| Year Ending Dec-13 | 1 | 0 | 17 | 0 |
| Year Ending Dec-14 | 0 | 1 | 12 | 5 |
- WellPoint profit beats, executives plan for health reform
- UPDATE 3-WellPoint profit beats, execs plan for health reform
- BRIEF-WellPoint CEO says evaluating its investment in private Medicare
- WellPoint profit rises; some medical costs low
- WellPoint says first-quarter profit rises, raises 2013 outlook
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (WLP). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Jefferson Research
|
$20.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates